PANTHERx® Rare Selected by Aadi Bioscience to Distribute FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for advanced malignant perivascular epithelioid cell neoplasm (PEComa)
February 24, 2022 PANTHERx® Rare announces that it has been selected by Aadi Bioscience as the exclusive U.S. pharmacy distribution...
Read More
PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome
January 13, 2022 PANTHERx® Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary...
Read More
2021 Marks Milestone Fourth Patient Choice Award for PANTHERx Rare
Read the Official PANTHERx Press Release. PANTHERx Rare has again been recognized as the winner of the annual, national Specialty...
Read More
PANTHERx® Rare Pharmacy Selected by ChemoCentryx to Distribute TAVNEOS™ (avacopan) in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy announces that it has been selected by ChemoCentryx as a...
Read More
PANTHERx® Rare Pharmacy Selected by Rhythm Pharmaceuticals to Distribute IMCIVREE™ (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announced today that it was selected by Rhythm Pharmaceuticals...
Read More
Centene Signs Definitive Agreement to Acquire PANTHERx Rare Pharmacy (PANTHERx)
Today is a transformative day and the culmination of a great deal of effort and diligence to support the future of PANTHERx....
Read More
